The global cardioverter defibrillator devices market is expected to grow at a CAGR of 4.6% during the forecast period to reach USD 12,520.0 million by 2022, says “Meticulous Research”. The global cardioverter defibrillator devices market is expected to grow at a CAGR of 4.6% during the forecast period to reach USD 12,520.0 million by 2022, says […]Read More..
The global ventilators market is estimated to be valued at USD 1,865.6 million in 2018 and is projected to grow at a CAGR of 7.2% during 2018 to 2023, to reach USD 2,636.2 million by 2023, says “Meticulous Research”. Ventilatory intervention is often life-saving when patients with asthma or chronic obstructive pulmonary disease (COPD) experience acute […]Read More..
The IVD test results influence ~70% of the total health care decisions with only ~4% of the total healthcare spending. The errors in the results of these IVD tests can severely impact and impose the health and life of humans at risk. And hence, the medical laboratories have ensured the accuracy and reliability of their […]Read More..
Diabetes is a chronic metabolic disorder resulting from defects of insulin secretion and/or action. Type 1 diabetes (T1D) is characterized by a lack of insulin secretion by the pancreas and can be treated by exogenous administration of insulin, while Type 2 diabetes (T2D) whose onset is often facilitated by bad daily habits, e.g., physical inactivity […]Read More..
Rising demand for Therapeutic Plasma Exchange (TPE) Procedure for the treatment of autoimmune diseases directly influencing the plasmapheresis market
Therapeutic plasma exchange (TPE) is the commonly used treatment in many autoimmune, neurological, renal, and hematological disorders. The autoimmune diseases such as multiple sclerosis, cryoglobulinemia, myasthenia gravis, Guillain-Barre syndrome, chronic inflammatory demyelinating polyneuropathy (CIDP), rheumatoid arthritis, and type 1 diabetes; commonly use TPE as the first line therapy. Many autoimmune diseases based on immune pathogenesis […]Read More..